Type 1 and 2 diabetes are associated with reduced natural killer cell cytotoxicity

Dae Yoon Kim1, Jae Kwon Lee2

  • 1College of Pharmacy, Chungbuk National University, Chungbuk 361-763, Republic of Korea.

Cellular Immunology
|July 31, 2022
PubMed

Insights

Diabetes mellitus (DM) impairs natural killer (NK) cell activity, reducing their ability to fight cancer. High blood sugar levels in diabetic mice led to decreased NK cell function and activation markers.

Area of Science:

  • Immunology
  • Endocrinology
  • Metabolic Disorders

Background:

  • Diabetes mellitus (DM) is a chronic metabolic disorder linked to immune system dysfunction.
  • Natural killer (NK) cells are crucial for innate immunity and cancer surveillance.
  • Understanding how diabetes affects NK cell activity is vital for managing complications.

Purpose of the Study:

  • To investigate the impact of hyperglycemia on NK cell activity in diabetes.
  • To analyze changes in NK cell cytotoxic function and activation markers under diabetic conditions.

Main Methods:

  • Type 1 and type 2 diabetes mellitus mouse models were established.
  • NK cell activity and expression of activation markers (NKG2D, NKp46) were assessed.
  • Granzyme B production in NK cells was measured.

Main Results:

  • NK cells from diabetic mice exhibited significantly lower cytotoxic activity against cancer cells compared to controls.
  • Reduced NK cell activity correlated with the duration of diabetes.
  • Diabetic NK cells showed decreased expression of activation markers NKG2D and NKp46.
  • Production of the cytotoxic molecule granzyme B was diminished in NK cells from diabetic mice.

Conclusions:

  • Hyperglycemia associated with diabetes mellitus negatively impacts NK cell function.
  • Diabetes compromises NK cell-mediated immune responses, potentially increasing susceptibility to infections and cancer.
  • These findings highlight a critical link between metabolic health and immune surveillance.

Related Concept Videos

Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...